Yuan-Ching Liu

Person

San Diego, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Heterocyclic spiro compounds and methods of use thereof for the tre...
- Patent number 12,134,620
- Issue date Nov 5, 2024
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted quinazolines as inhibitors of KRAS G12C
- Patent number 11,878,985
- Issue date Jan 23, 2024
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinazoline derivatives as modulators of mutant KRAS, HRAS or NRAS
- Patent number 11,639,346
- Issue date May 2, 2023
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Covalent inhibitors of KRAS
- Patent number 11,377,441
- Issue date Jul 5, 2022
- ARAXES PHARMA LLC
- Liansheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Benzothiophene and benzothiazole compounds and methods of use thereof
- Patent number 11,358,959
- Issue date Jun 14, 2022
- ARAXES PHARMA LLC
- Liansheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1 yl)pro...
- Patent number 11,279,689
- Issue date Mar 22, 2022
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused bicyclic benzoheteroaromatic compounds and methods of use the...
- Patent number 11,274,093
- Issue date Mar 15, 2022
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted quinazoline and quinazolinone compounds and methods of...
- Patent number 11,136,308
- Issue date Oct 5, 2021
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused hetero-hetero bicyclic compounds and methods of use thereof
- Patent number 11,059,819
- Issue date Jul 13, 2021
- Janssen Biotech, Inc.
- Liansheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-substituted quinazoline compounds comprising a substituted hetero...
- Patent number 11,021,470
- Issue date Jun 1, 2021
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of KRAS G12C mutant proteins
- Patent number 10,975,071
- Issue date Apr 13, 2021
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted cinnolines as inhibitors of KRAS G12C
- Patent number 10,927,125
- Issue date Feb 23, 2021
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted quinazoline compounds and methods of use thereof
- Patent number 10,829,458
- Issue date Nov 10, 2020
- Araxes Pharma LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Covalent inhibitors of KRAS
- Patent number 10,745,385
- Issue date Aug 18, 2020
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and methods of use thereof for treatment of cancer
- Patent number 10,736,897
- Issue date Aug 11, 2020
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of KRAS G12C mutant proteins
- Patent number 10,723,738
- Issue date Jul 28, 2020
- ARAXES PHARMA LLC
- Liansheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of KRAS G12C mutant proteins
- Patent number 10,689,356
- Issue date Jun 23, 2020
- ARAXES PHARMA LLC
- Liansheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused-tricyclic inhibitors of KRAS and methods of use thereof
- Patent number 10,428,064
- Issue date Oct 1, 2019
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-substituted quinazoline compounds comprising a substituted hetero...
- Patent number 10,414,757
- Issue date Sep 17, 2019
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of RAS and methods of use thereof
- Patent number 10,377,743
- Issue date Aug 13, 2019
- ARAXES PHARMA LLC
- Liansheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted quinolines as inhibitors of KRAS G12C
- Patent number 10,370,386
- Issue date Aug 6, 2019
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted quinazoline compounds and methods of use thereof
- Patent number 10,351,550
- Issue date Jul 16, 2019
- ARAXES PHARMA LLC
- Liansheng Li
- G01 - MEASURING TESTING
Information Patent Grant
Inhibitors of KRAS G12C mutant proteins
- Patent number 10,280,172
- Issue date May 7, 2019
- ARAXES PHARMA LLC
- Liansheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted quinazoline compounds and methods of use thereof
- Patent number 10,246,424
- Issue date Apr 2, 2019
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted quinazoline compounds and methods of use thereof
- Patent number 10,144,724
- Issue date Dec 4, 2018
- Araxes Pharma LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for preparation of quinazoline derivatives
- Patent number 9,988,357
- Issue date Jun 5, 2018
- Araxes Pharma LLC
- Neelakandha S. Mani
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted quinazolines as inhibitors of KRAS G12C
- Patent number 9,840,516
- Issue date Dec 12, 2017
- Araxes Pharma LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
HETEROCYCLIC COMPOUNDS AND USES THEREOF
- Publication number 20240368191
- Publication date Nov 7, 2024
- KUMQUAT BIOSCIENCES INC.
- Xiaoming Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED QUINAZOLINES AS INHIBITORS OF KRAS G12C
- Publication number 20240352028
- Publication date Oct 24, 2024
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AND USES THEREOF
- Publication number 20240254129
- Publication date Aug 1, 2024
- KUMQUAT BIOSCIENCES INC.
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AND USES THEREOF
- Publication number 20240116951
- Publication date Apr 11, 2024
- KUMQUAT BIOSCIENCES INC.
- Xiaoming Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AND USES THEREOF
- Publication number 20240109918
- Publication date Apr 4, 2024
- KUMQUAT BIOSCIENCES INC.
- Xiaoming Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF KRAS G12C
- Publication number 20240043441
- Publication date Feb 8, 2024
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF KRAS G12C
- Publication number 20230303586
- Publication date Sep 28, 2023
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF KRAS G12C
- Publication number 20230212183
- Publication date Jul 6, 2023
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COVALENT INHIBITORS OF KRAS
- Publication number 20230203018
- Publication date Jun 29, 2023
- ARAXES PHARMA LLC
- Liansheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED N-HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF
- Publication number 20230147053
- Publication date May 11, 2023
- ARAXES PHARMA LLC
- Liansheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF KRAS G12C
- Publication number 20220242875
- Publication date Aug 4, 2022
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION OF A CDK INHIBITOR AND A PIM INHIBITOR
- Publication number 20220125777
- Publication date Apr 28, 2022
- Pfizer Inc.
- Zhou Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF CANCER
- Publication number 20220112192
- Publication date Apr 14, 2022
- ARAXES PHARMA LLC
- Liansheng LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-(2-ACRYLOYL-2,6-DIAZASPIRO[3.4]OCTAN-6-YL)-6-(1H-INDAZOL-4-YL)-BE...
- Publication number 20210380595
- Publication date Dec 9, 2021
- ARAXES PHARMA LLC
- Liansheng LI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC SPIRO COMPOUNDS AND METHODS OF USE THEREOF FOR THE TRE...
- Publication number 20210317127
- Publication date Oct 14, 2021
- ARAXES PHARMA LLC
- Liansheng LI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF KRAS G12C
- Publication number 20210188869
- Publication date Jun 24, 2021
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COVALENT INHIBITORS OF KRAS
- Publication number 20210024501
- Publication date Jan 28, 2021
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED N-HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF
- Publication number 20200385364
- Publication date Dec 10, 2020
- Liansheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-SUBSTITUTED QUINAZOLINE COMPOUNDS COMPRISING A SUBSTITUTED HETERO...
- Publication number 20200181123
- Publication date Jun 11, 2020
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
QUINAZOLINE DERIVATIVES AS MODULATORS OF MUTANT KRAS, HRAS OR NRAS
- Publication number 20200115363
- Publication date Apr 16, 2020
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED QUINAZOLINES AS INHIBITORS OF KRAS G12C
- Publication number 20200102321
- Publication date Apr 2, 2020
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF KRAS G12C MUTANT PROTEINS
- Publication number 20200062761
- Publication date Feb 27, 2020
- ARAXES PHARMA LLC
- Liansheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED QUINAZOLINE AND QUINAZOLINONE COMPOUNDS AND METHODS OF...
- Publication number 20200010454
- Publication date Jan 9, 2020
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BENZOTHIOPHENE AND BENZOTHIAZOLE COMPOUNDS AND METHODS OF USE THEREOF
- Publication number 20190389851
- Publication date Dec 26, 2019
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1-(3-(6-(3-HYDROXYNAPHTHALEN-1-YL)BENZOFURAN-2-YL)AZETIDIN-1 YL)PRO...
- Publication number 20190382377
- Publication date Dec 19, 2019
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED BICYCLIC BENZOHETEROAROMATIC COMPOUNDS AND METHODS OF USE THE...
- Publication number 20190367489
- Publication date Dec 5, 2019
- ARAXES PHARMA LLC
- Liansheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED HETERO-HETERO BICYCLIC COMPOUNDS AND METHODS OF USE THEREOF
- Publication number 20190345158
- Publication date Nov 14, 2019
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF
- Publication number 20190284144
- Publication date Sep 19, 2019
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF KRAS G12C MUTANT PROTEINS
- Publication number 20190092767
- Publication date Mar 28, 2019
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COVALENT INHIBITORS OF KRAS
- Publication number 20190062313
- Publication date Feb 28, 2019
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY

Yuan-Ching Liu

Person

Patents Grantslast 30 patents

Heterocyclic spiro compounds and methods of use thereof for the tre...

Substituted quinazolines as inhibitors of KRAS G12C

Quinazoline derivatives as modulators of mutant KRAS, HRAS or NRAS

Covalent inhibitors of KRAS

Benzothiophene and benzothiazole compounds and methods of use thereof

1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1 yl)pro...

Fused bicyclic benzoheteroaromatic compounds and methods of use the...

Substituted quinazoline and quinazolinone compounds and methods of...

Fused hetero-hetero bicyclic compounds and methods of use thereof

2-substituted quinazoline compounds comprising a substituted hetero...

Inhibitors of KRAS G12C mutant proteins

Substituted cinnolines as inhibitors of KRAS G12C

Substituted quinazoline compounds and methods of use thereof

Covalent inhibitors of KRAS

Compounds and methods of use thereof for treatment of cancer

Inhibitors of KRAS G12C mutant proteins

Inhibitors of KRAS G12C mutant proteins

Fused-tricyclic inhibitors of KRAS and methods of use thereof

2-substituted quinazoline compounds comprising a substituted hetero...

Inhibitors of RAS and methods of use thereof

Substituted quinolines as inhibitors of KRAS G12C

Substituted quinazoline compounds and methods of use thereof

Inhibitors of KRAS G12C mutant proteins

Substituted quinazoline compounds and methods of use thereof

Substituted quinazoline compounds and methods of use thereof

Methods for preparation of quinazoline derivatives

Substituted quinazolines as inhibitors of KRAS G12C

Patents Applicationslast 30 patents

HETEROCYCLIC COMPOUNDS AND USES THEREOF

SUBSTITUTED QUINAZOLINES AS INHIBITORS OF KRAS G12C

HETEROCYCLIC COMPOUNDS AND USES THEREOF

HETEROCYCLIC COMPOUNDS AND USES THEREOF

HETEROCYCLIC COMPOUNDS AND USES THEREOF

INHIBITORS OF KRAS G12C

INHIBITORS OF KRAS G12C

INHIBITORS OF KRAS G12C

COVALENT INHIBITORS OF KRAS

FUSED N-HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF

INHIBITORS OF KRAS G12C

COMBINATION OF A CDK INHIBITOR AND A PIM INHIBITOR

COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF CANCER

2-(2-ACRYLOYL-2,6-DIAZASPIRO[3.4]OCTAN-6-YL)-6-(1H-INDAZOL-4-YL)-BE...

HETEROCYCLIC SPIRO COMPOUNDS AND METHODS OF USE THEREOF FOR THE TRE...

INHIBITORS OF KRAS G12C

COVALENT INHIBITORS OF KRAS

FUSED N-HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF

2-SUBSTITUTED QUINAZOLINE COMPOUNDS COMPRISING A SUBSTITUTED HETERO...

QUINAZOLINE DERIVATIVES AS MODULATORS OF MUTANT KRAS, HRAS OR NRAS

SUBSTITUTED QUINAZOLINES AS INHIBITORS OF KRAS G12C

INHIBITORS OF KRAS G12C MUTANT PROTEINS

SUBSTITUTED QUINAZOLINE AND QUINAZOLINONE COMPOUNDS AND METHODS OF...

BENZOTHIOPHENE AND BENZOTHIAZOLE COMPOUNDS AND METHODS OF USE THEREOF

1-(3-(6-(3-HYDROXYNAPHTHALEN-1-YL)BENZOFURAN-2-YL)AZETIDIN-1 YL)PRO...

FUSED BICYCLIC BENZOHETEROAROMATIC COMPOUNDS AND METHODS OF USE THE...

FUSED HETERO-HETERO BICYCLIC COMPOUNDS AND METHODS OF USE THEREOF

SUBSTITUTED QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF

INHIBITORS OF KRAS G12C MUTANT PROTEINS

COVALENT INHIBITORS OF KRAS